“Scar tissue formed after surgery or injury often ends up being painful and limiting movement for patients. Although there are a number of possible treatments, these options are expensive and often have only limited success. According to Drs. Michael Mont, Morad Chughtai, Jared Newman, and their colleagues, a revolutionary new approach is now available. Called Astym therapy, the new method works by stimulating the body’s own mechanisms of regeneration for soft tissues and re-absorption of scar tissue. Crucially, after treatment, patients report significant improvements in mobility and pain relief…“
"*" indicates required fields
Read the full transcript of the podcast below:
“Scar tissue formed after surgery or injury often ends up being painful and limiting movement for patients. Although there are a number of possible treatments, these options are expensive and often have only limited success. According to Drs. Michael Mont, Morad Chughtai (chug-tie), Jared Newman, and their colleagues, a revolutionary new approach is now available. Called Astym (A-stim) therapy, the new method works by stimulating the body’s own mechanisms of regeneration for soft tissues and re-absorption of scar tissue. Crucially, after treatment, patients report significant improvements in mobility and pain relief.
For most people, scars are nothing more than a reminder of a past injury or accident. For some patients, however, scarring can become painful, swollen and severely restrict movement. This does not apply so much to visible scars on top of the skin, but more likely to be the case if the scars occur deep inside the body, in soft tissues, such as muscles, tendons, and ligaments. These scars can be caused in a variety of ways, including accidents and injuries, surgery, and even after intense muscular use such as in sports activities. Scarring is a normal process in the body. For example, a minor wound such as a cut in a finger will leave a red and raised line for a while, but it will gradually fade over time. Some scars don’t heal so easily however, and may continue to grow even after the wound itself has healed. The strong scar tissue is supposed to protect the affected area, but instead, it can end up causing serious pain and discomfort. Not surprisingly, patients in this situation often complain of a lower quality of life. …
There are a number of first-line treatments currently used, such as anti-inflammatory creams, corticosteroid (kor·tuh-ko·steh·royd) injections, cryotherapy or heat therapy, stretching and neuromuscular stimulation. The problem is that these options are often unsuccessful and when faced with a situation where nothing works, physicians may be tempted to move on to more invasive procedures, including surgery, to remove the scar tissue. However, there is a new kid on the block to treat these conditions. Known as Astym therapy, this clever approach takes advantage of the body’s natural mechanisms to regenerate soft tissues and eliminate the annoying scar tissue that is most likely the culprit for pain and restricted mobility.
It’s important to emphasize that this approach is different from a treatment known as Instrument Assisted Soft Tissue Mobilization, which is markedly different in application and goals. Instrument Assisted soft tissue mobilization uses aggressive scraping across the affected area in an attempt to mechanically break down the scar tissue, whereas Astym therapy applies instruments to the body through specific protocols to harness the body’s regenerative mechanisms to gently eliminate scarring. Perhaps Astym therapy’s superiority to less optimal approaches is because it was developed “methodically from theory through basic science investigation to clinical study and practice.” … Going down to the cellular level, Astym therapy stimulates the activity of a specific group of cells involved in wound healing known as fibroblasts (fy·bro·blaasts).
These cells have the ability to remodel the affected area, by dissolving the original scar and replacing it with higher quality tissue, resembling the normal tissue that was there before. In practical terms, the method uses a device applied topically along the skin following specific protocols for direction, application, and forces imparted to locate and restore the abnormal soft tissue underneath. The treatment is complete with a customized stretching and strengthening program devised to allow the patient’s body to heal correctly. This is an integral part of the process, to ensure the newly forming fibers stay strong and properly align, which allows symptoms of pain to dissipate and functional movement patterns to be restored.
As the cherry on top of the cake, Astym therapy actually works quite quickly, and a typical course of treatment takes two sessions per week for only four to six weeks. During this period, the patient is encouraged to continue with normal activities to optimize tissue quality. … For Mont, Chughtai, Newman and their colleagues, the best aspect about Astym therapy is the fact that it was born from scientific research examining the underlying problems and the healing mechanisms at a cellular level. This knowledge was then applied to real patients across multiple controlled clinical trials and other studies.
This ground-breaking endeavor was only accomplished thanks to the multidisciplinary research team that included scientists, doctors, and therapists. In all the studies, Astym therapy has been shown to be safe and highly effective. However, the number of studies assessing this new treatment could be expanded. To understand the current evidence-base for Astym therapy, Drs. Michael Mont, Morad Chughtai, Jared Newman and their colleagues conducted a review of all studies published on Astym therapy, which include treatment results on various parts of the body and various conditions.
Patients with persistent injuries in the hip, thigh, knee and ankle regions treated with Astym therapy reported significant improvements in mobility and less pain. For most of these patients, this meant pain-free walking and a return to normal activities. Similarly, Astym therapy seems to provide relief and increased range of motion in the shoulder for patients who have developed soft tissue restrictions after undergoing breast removal to treat cancer. More importantly, these women noted a decrease in their scar hypersensitivity. …
These preliminary studies support the fact that Astym therapy doesn’t just treat the symptoms or mask the problem temporarily. Instead, it can stimulate the body to regenerate healthy tissue and heal completely, permanently, eliminating pain. In fact, the researchers believe incorporating this method into standard rehabilitation procedures has the potential to improve mobility and reduce pain in patients after surgery or injuries. Studies completed consistently confirm this new treatment is a safe and effective option for patients suffering from a variety of conditions.“
Meet the Researchers:
Morad Chughtai, Department of Orthopaedic Surgery, Cleveland Clinic Jared M. Newman, Department of Orthopedic Surgery, SUNY Downstate Medical Center Assem A. Sultan, Department of Orthopaedic Surgery, Cleveland Clinic Linsen T. Samuel, Department of Orthopaedic Surgery, Cleveland Clinic Jacob Rabin, Department of Orthopaedic Surgery, Cleveland Clinic Anton Khlopas, Department of Orthopaedic Surgery, Cleveland Clinic Anil Bhave, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore Michael A. Mont, Department of Orthopaedic Surgery, Lenox Hill Hospital
This SciPod is a summary of paper ‘Astym® therapy: a systematic review’ from the Annals of Translational Medicine: https://dx.doi.org/10.21037/atm.2018.11.49
Other Articles You Might Like:
Live online certification courses available! |
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-advertisement | 1 year | Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category . |
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
CookieLawInfoConsent | 1 year | Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie. |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Cookie | Duration | Description |
---|---|---|
bcookie | 2 years | LinkedIn sets this cookie from LinkedIn share buttons and ad tags to recognize browser ID. |
bscookie | 2 years | LinkedIn sets this cookie to store performed actions on the website. |
lang | session | LinkedIn sets this cookie to remember a user's language setting. |
lidc | 1 day | LinkedIn sets the lidc cookie to facilitate data center selection. |
na_id | 1 year 24 days | The na_id is set by AddThis to enable sharing of links on social media platforms like Facebook and Twitter. |
ouid | 1 year 24 days | Associated with the AddThis widget, this cookie helps users to share content across various networking and sharing forums. |
UserMatchHistory | 1 month | LinkedIn sets this cookie for LinkedIn Ads ID syncing. |
Cookie | Duration | Description |
---|---|---|
__utma | 2 years | This cookie is set by Google Analytics and is used to distinguish users and sessions. The cookie is created when the JavaScript library executes and there are no existing __utma cookies. The cookie is updated every time data is sent to Google Analytics. |
__utmb | 30 minutes | Google Analytics sets this cookie, to determine new sessions/visits. __utmb cookie is created when the JavaScript library executes and there are no existing __utma cookies. It is updated every time data is sent to Google Analytics. |
__utmc | session | The cookie is set by Google Analytics and is deleted when the user closes the browser. It is used to enable interoperability with urchin.js, which is an older version of Google Analytics and is used in conjunction with the __utmb cookie to determine new sessions/visits. |
__utmt | 10 minutes | Google Analytics sets this cookie to inhibit request rate. |
__utmz | 6 months | Google Analytics sets this cookie to store the traffic source or campaign by which the visitor reached the site. |
Cookie | Duration | Description |
---|---|---|
uid | 1 year 24 days | This is a Google UserID cookie that tracks users across various website segments. |
Cookie | Duration | Description |
---|---|---|
__ss | 1 day | This cookie is set by SharpSpring, a marketing automation platform. This is used for tracking visitors and form submissions. |
__ss_referrer | 1 hour | This cookie is set by SharpSpring, a marketing automation platform. This is used for tracking visitors and form submissions. |
__ss_tk | 25 years | This cookie is set by SharpSpring, a marketing automation platform. This is used for tracking visitors and form submissions. |
_fbp | 3 months | This cookie is set by Facebook to display advertisements when either on Facebook or on a digital platform powered by Facebook advertising, after visiting the website. |
anj | 3 months | AppNexus sets the anj cookie that contains data stating whether a cookie ID is synced with partners. |
fr | 3 months | Facebook sets this cookie to show relevant advertisements to users by tracking user behaviour across the web, on sites that have Facebook pixel or Facebook social plugin. |
IDE | 1 year 24 days | Google DoubleClick IDE cookies are used to store information about how the user uses the website to present them with relevant ads and according to the user profile. |
IDSYNC | 1 year | This cookie is set by Yahoo to store information on how users behave on multiple websites so that relevant ads can be displayed to them. |
koitk | 10 years | This cookie is set by SharpSpring, a marketing automation platform. This is used for tracking visitors and form submissions. |
pa_crosswise_ts | 2 years | The pa_crosswise_ts cookie is set by Perfect Audience for advertising purposes based on user behavioural data. |
pa_google_ts | 2 years | The pa_google_ts cookie is set by Perfect Audience for advertising purposes based on user behavioural data. |
pa_openx_ts | 2 years | The pa_openx_ts cookie is set by Perfect Audience for advertising purposes based on user behavioural data. |
pa_rubicon_ts | 2 years | The pa_rubicon_ts cookie is set by Perfect Audience for advertising purposes based on user behavioural data. |
pa_twitter_ts | 2 years | The pa_twitter_ts cookie is set by Perfect Audience for advertising purposes based on user behavioural data. |
pa_uid | 2 years | This cookie is set by prfct.co. This cookie is used across the websites that use same ad network to display ads to the other advertisers in the network. |
pa_yahoo_ts | 2 years | The pa_yahoo_ts cookie is set by Perfect Audience for advertising purposes based on user behavioural data. |
personalization_id | 2 years | Twitter sets this cookie to integrate and share features for social media and also store information about how the user uses the website, for tracking and targeting. |
test_cookie | 15 minutes | The test_cookie is set by doubleclick.net and is used to determine if the user's browser supports cookies. |
uuid2 | 3 months | The uuid2 cookie is set by AppNexus and records information that helps in differentiating between devices and browsers. This information is used to pick out ads delivered by the platform and assess the ad performance and its attribute payment. |
Cookie | Duration | Description |
---|---|---|
_ce.s | 1 year | No description |
_gd_logged_out_post_author | session | No description available. |
A3 | 1 year | No description |
AnalyticsSyncHistory | 1 month | No description |
cebs | session | No description |
cebsp | session | No description |
li_gc | 2 years | No description |
There are currently no in-person Astym courses available.
Sign up to never miss out on an Astym course near you or contact us to see if you qualify for on-site training to minimize time out of the clinic and travel expenses.
Blended Learning
Online work before live course
8 hours/day for in-person portion
6-10 hours to complete online work
Eligible for up to 29.25 CEUs
Self-Paced
1:1 exams with instructors via Zoom
Access for 60 days
Up to 28 hours to complete
Eligible for up to 28 CEUs
The value of the Astym Certification remains the same whether a clinician has been certified through our hybrid learning experience or our online course experience. Both educational opportunities require intensive online training and interactive practical exams with an Astym Certified Instructor.